Navigating Change: Insights from Mike Tomasco's Journey in Digital Transformation
Navigating Change: Insights from Mike Tomasco's Journey in Digital Transformation
Mike Tomasco, VP of Pfizer Digital, leverages nearly 20 years of experience to drive transformation, emphasizing adaptability, problem-solving, and strategic storytelling
By
Mike Tomasco
September 12, 2024
6
min read
In this article
6
min read
In a fast-evolving digital world, where innovation shapes both opportunity and disruption, seasoned leaders like Mike Tomasco have become pivotal in guiding organizations through transformation. Tomasco, with close to two decades of experience at Pfizer—culminating in his role as Vice President of Pfizer Digital—has been a driving force in not only navigating change but leading it. His experiences reveal valuable insights into fostering problem-solving, adaptability, and the strategic power of storytelling in shaping organizational success.
In a fast-evolving digital world, where innovation shapes both opportunity and disruption, seasoned leaders like Mike Tomasco have become pivotal in guiding organizations through transformation. Tomasco, with close to two decades of experience at Pfizer—culminating in his role as Vice President of Pfizer Digital—has been a driving force in not only navigating change but leading it. His experiences reveal valuable insights into fostering problem-solving, adaptability, and the strategic power of storytelling in shaping organizational success.
In a fast-evolving digital world, where innovation shapes both opportunity and disruption, seasoned leaders like Mike Tomasco have become pivotal in guiding organizations through transformation. Tomasco, with close to two decades of experience at Pfizer—culminating in his role as Vice President of Pfizer Digital—has been a driving force in not only navigating change but leading it. His experiences reveal valuable insights into fostering problem-solving, adaptability, and the strategic power of storytelling in shaping organizational success.
In a fast-evolving digital world, where innovation shapes both opportunity and disruption, seasoned leaders like Mike Tomasco have become pivotal in guiding organizations through transformation. Tomasco, with close to two decades of experience at Pfizer—culminating in his role as Vice President of Pfizer Digital—has been a driving force in not only navigating change but leading it. His experiences reveal valuable insights into fostering problem-solving, adaptability, and the strategic power of storytelling in shaping organizational success.
AI is not a magical solution; it’s a powerful tool when paired with robust data
AI is not a magical solution; it’s a powerful tool when paired with robust data
AI is not a magical solution; it’s a powerful tool when paired with robust data
AI is not a magical solution; it’s a powerful tool when paired with robust data
Embracing Complexity with a Problem-Solving Mindset
Tomasco’s career began with a decade at Accenture, where his initial five years focused on bio-manufacturing. Here, he developed a key competency in problem-solving, a skill that would underpin his career trajectory. “Every problem is easy to solve until proven otherwise,” he notes, emphasizing the layered complexity of biopharma processes, where minor disruptions can have substantial repercussions. Tomasco’s approach reframes obstacles as opportunities for innovation, a critical mindset in bio-manufacturing, where stringent process continuity is paramount.
This problem-solving mindset is particularly relevant in the biopharma space, where disruptions not only impede progress but threaten operational integrity. Tomasco emphasizes future-proofing solutions, building systems that can adapt and integrate new capabilities without compromising operational stability. By methodically addressing challenges and breaking them down into manageable components, Tomasco has encouraged his teams to adopt a proactive, rather than reactive, approach to complex problem-solving.
Tomasco’s career began with a decade at Accenture, where his initial five years focused on bio-manufacturing. Here, he developed a key competency in problem-solving, a skill that would underpin his career trajectory. “Every problem is easy to solve until proven otherwise,” he notes, emphasizing the layered complexity of biopharma processes, where minor disruptions can have substantial repercussions. Tomasco’s approach reframes obstacles as opportunities for innovation, a critical mindset in bio-manufacturing, where stringent process continuity is paramount.
This problem-solving mindset is particularly relevant in the biopharma space, where disruptions not only impede progress but threaten operational integrity. Tomasco emphasizes future-proofing solutions, building systems that can adapt and integrate new capabilities without compromising operational stability. By methodically addressing challenges and breaking them down into manageable components, Tomasco has encouraged his teams to adopt a proactive, rather than reactive, approach to complex problem-solving.
Tomasco’s career began with a decade at Accenture, where his initial five years focused on bio-manufacturing. Here, he developed a key competency in problem-solving, a skill that would underpin his career trajectory. “Every problem is easy to solve until proven otherwise,” he notes, emphasizing the layered complexity of biopharma processes, where minor disruptions can have substantial repercussions. Tomasco’s approach reframes obstacles as opportunities for innovation, a critical mindset in bio-manufacturing, where stringent process continuity is paramount.
This problem-solving mindset is particularly relevant in the biopharma space, where disruptions not only impede progress but threaten operational integrity. Tomasco emphasizes future-proofing solutions, building systems that can adapt and integrate new capabilities without compromising operational stability. By methodically addressing challenges and breaking them down into manageable components, Tomasco has encouraged his teams to adopt a proactive, rather than reactive, approach to complex problem-solving.
Tomasco’s career began with a decade at Accenture, where his initial five years focused on bio-manufacturing. Here, he developed a key competency in problem-solving, a skill that would underpin his career trajectory. “Every problem is easy to solve until proven otherwise,” he notes, emphasizing the layered complexity of biopharma processes, where minor disruptions can have substantial repercussions. Tomasco’s approach reframes obstacles as opportunities for innovation, a critical mindset in bio-manufacturing, where stringent process continuity is paramount.
This problem-solving mindset is particularly relevant in the biopharma space, where disruptions not only impede progress but threaten operational integrity. Tomasco emphasizes future-proofing solutions, building systems that can adapt and integrate new capabilities without compromising operational stability. By methodically addressing challenges and breaking them down into manageable components, Tomasco has encouraged his teams to adopt a proactive, rather than reactive, approach to complex problem-solving.
The Importance of Adaptability and Risk-Taking
Throughout his tenure at Pfizer, Tomasco’s adaptability emerged as a defining strength. He readily embraced new roles and challenges, believing that continuous learning and adaptation are critical for navigating corporate environments characterized by rapid change. “I was a big fan of raising my hand to try new things,” he explains, recalling his time on a strategic team envisioning the future of Pfizer’s global supply and finance functions. This role demanded not only strategic thinking but also a strong influence to unite disparate teams under common goals.
Tomasco’s willingness to step out of his comfort zone also underscored his understanding that effective leadership requires not only risk-taking but also the ability to foster collaboration across organizational boundaries. His proactive approach to career growth reveals a commitment to both personal and organizational evolution, a hallmark of transformative leadership.
Throughout his tenure at Pfizer, Tomasco’s adaptability emerged as a defining strength. He readily embraced new roles and challenges, believing that continuous learning and adaptation are critical for navigating corporate environments characterized by rapid change. “I was a big fan of raising my hand to try new things,” he explains, recalling his time on a strategic team envisioning the future of Pfizer’s global supply and finance functions. This role demanded not only strategic thinking but also a strong influence to unite disparate teams under common goals.
Tomasco’s willingness to step out of his comfort zone also underscored his understanding that effective leadership requires not only risk-taking but also the ability to foster collaboration across organizational boundaries. His proactive approach to career growth reveals a commitment to both personal and organizational evolution, a hallmark of transformative leadership.
Throughout his tenure at Pfizer, Tomasco’s adaptability emerged as a defining strength. He readily embraced new roles and challenges, believing that continuous learning and adaptation are critical for navigating corporate environments characterized by rapid change. “I was a big fan of raising my hand to try new things,” he explains, recalling his time on a strategic team envisioning the future of Pfizer’s global supply and finance functions. This role demanded not only strategic thinking but also a strong influence to unite disparate teams under common goals.
Tomasco’s willingness to step out of his comfort zone also underscored his understanding that effective leadership requires not only risk-taking but also the ability to foster collaboration across organizational boundaries. His proactive approach to career growth reveals a commitment to both personal and organizational evolution, a hallmark of transformative leadership.
Throughout his tenure at Pfizer, Tomasco’s adaptability emerged as a defining strength. He readily embraced new roles and challenges, believing that continuous learning and adaptation are critical for navigating corporate environments characterized by rapid change. “I was a big fan of raising my hand to try new things,” he explains, recalling his time on a strategic team envisioning the future of Pfizer’s global supply and finance functions. This role demanded not only strategic thinking but also a strong influence to unite disparate teams under common goals.
Tomasco’s willingness to step out of his comfort zone also underscored his understanding that effective leadership requires not only risk-taking but also the ability to foster collaboration across organizational boundaries. His proactive approach to career growth reveals a commitment to both personal and organizational evolution, a hallmark of transformative leadership.
Breaking Down Silos: A Collaborative Approach
Tomasco’s journey reflects a commitment to dismantling organizational silos. At Pfizer, he championed the idea of establishing cross-functional teams capable of uniting various departments—from manufacturing to quality assurance—to drive cohesive, data-informed decision-making. His approach, characterized by questions like “What if a group worked across all that?” helped foster a collaborative ethos, where a unified team structure became central to Pfizer’s transformative strategies.
However, breaking down silos was not without its challenges. Resistance to change often accompanied Tomasco’s initiatives. Here, he turned to storytelling as a tool, rebranding and reintroducing his concepts to various stakeholders, framing a shared vision of how consolidated data could streamline operations and enhance outcomes. Through his advocacy for a “Single Pane of Glass” concept, Tomasco demonstrated that effective collaboration requires not only vision but also the ability to communicate and align diverse teams toward shared goals.
Tomasco’s journey reflects a commitment to dismantling organizational silos. At Pfizer, he championed the idea of establishing cross-functional teams capable of uniting various departments—from manufacturing to quality assurance—to drive cohesive, data-informed decision-making. His approach, characterized by questions like “What if a group worked across all that?” helped foster a collaborative ethos, where a unified team structure became central to Pfizer’s transformative strategies.
However, breaking down silos was not without its challenges. Resistance to change often accompanied Tomasco’s initiatives. Here, he turned to storytelling as a tool, rebranding and reintroducing his concepts to various stakeholders, framing a shared vision of how consolidated data could streamline operations and enhance outcomes. Through his advocacy for a “Single Pane of Glass” concept, Tomasco demonstrated that effective collaboration requires not only vision but also the ability to communicate and align diverse teams toward shared goals.
Tomasco’s journey reflects a commitment to dismantling organizational silos. At Pfizer, he championed the idea of establishing cross-functional teams capable of uniting various departments—from manufacturing to quality assurance—to drive cohesive, data-informed decision-making. His approach, characterized by questions like “What if a group worked across all that?” helped foster a collaborative ethos, where a unified team structure became central to Pfizer’s transformative strategies.
However, breaking down silos was not without its challenges. Resistance to change often accompanied Tomasco’s initiatives. Here, he turned to storytelling as a tool, rebranding and reintroducing his concepts to various stakeholders, framing a shared vision of how consolidated data could streamline operations and enhance outcomes. Through his advocacy for a “Single Pane of Glass” concept, Tomasco demonstrated that effective collaboration requires not only vision but also the ability to communicate and align diverse teams toward shared goals.
Tomasco’s journey reflects a commitment to dismantling organizational silos. At Pfizer, he championed the idea of establishing cross-functional teams capable of uniting various departments—from manufacturing to quality assurance—to drive cohesive, data-informed decision-making. His approach, characterized by questions like “What if a group worked across all that?” helped foster a collaborative ethos, where a unified team structure became central to Pfizer’s transformative strategies.
However, breaking down silos was not without its challenges. Resistance to change often accompanied Tomasco’s initiatives. Here, he turned to storytelling as a tool, rebranding and reintroducing his concepts to various stakeholders, framing a shared vision of how consolidated data could streamline operations and enhance outcomes. Through his advocacy for a “Single Pane of Glass” concept, Tomasco demonstrated that effective collaboration requires not only vision but also the ability to communicate and align diverse teams toward shared goals.
Every problem is easy to solve until proven otherwise.
Every problem is easy to solve until proven otherwise.
Every problem is easy to solve until proven otherwise.
Every problem is easy to solve until proven otherwise.
The Power of User Experience in Digital Transformation
A cornerstone of Tomasco’s digital transformation strategy was prioritizing user experience (UX). Recognizing that digital tools can only drive meaningful change if they are user-centric, Tomasco integrated UX design from the start. This approach was crucial in addressing a key pain point: employees’ need to navigate multiple systems for daily tasks. Through careful feedback collection, particularly from the shop floor, Tomasco’s team identified the need for a consolidated platform. By focusing on intuitive, user-friendly solutions, Tomasco ensured that the digital transformation strategy not only streamlined operations but also addressed the real needs of end-users.
A cornerstone of Tomasco’s digital transformation strategy was prioritizing user experience (UX). Recognizing that digital tools can only drive meaningful change if they are user-centric, Tomasco integrated UX design from the start. This approach was crucial in addressing a key pain point: employees’ need to navigate multiple systems for daily tasks. Through careful feedback collection, particularly from the shop floor, Tomasco’s team identified the need for a consolidated platform. By focusing on intuitive, user-friendly solutions, Tomasco ensured that the digital transformation strategy not only streamlined operations but also addressed the real needs of end-users.
A cornerstone of Tomasco’s digital transformation strategy was prioritizing user experience (UX). Recognizing that digital tools can only drive meaningful change if they are user-centric, Tomasco integrated UX design from the start. This approach was crucial in addressing a key pain point: employees’ need to navigate multiple systems for daily tasks. Through careful feedback collection, particularly from the shop floor, Tomasco’s team identified the need for a consolidated platform. By focusing on intuitive, user-friendly solutions, Tomasco ensured that the digital transformation strategy not only streamlined operations but also addressed the real needs of end-users.
A cornerstone of Tomasco’s digital transformation strategy was prioritizing user experience (UX). Recognizing that digital tools can only drive meaningful change if they are user-centric, Tomasco integrated UX design from the start. This approach was crucial in addressing a key pain point: employees’ need to navigate multiple systems for daily tasks. Through careful feedback collection, particularly from the shop floor, Tomasco’s team identified the need for a consolidated platform. By focusing on intuitive, user-friendly solutions, Tomasco ensured that the digital transformation strategy not only streamlined operations but also addressed the real needs of end-users.
Leveraging AI for Enhanced Decision-Making
Tomasco’s forward-thinking approach extends into the domain of artificial intelligence (AI), where he sees immense potential to revolutionize decision-making processes in biopharma. However, he underscores the need for a robust data foundation to maximize AI’s benefits. “AI is not a magical solution; it’s a powerful tool when paired with robust data,” he explains. Tomasco’s insights align with recent FDA draft guidelines on AI, which aim to clarify the role of AI in drug manufacturing, particularly around quality control, predictive analytics, and real-time decision-making. The FDA emphasizes the importance of data integrity and transparency, reinforcing Tomasco’s advocacy for reliable, quality-focused data practices.
These new FDA guidelines set standards to mitigate risks associated with AI implementation and ensure consistent product quality in biopharma. They support Tomasco’s view on future-proofing by underlining that a solid foundation of data practices must precede AI deployment, enabling companies to enhance production reliability and predictability. These evolving regulatory standards reflect the broader industry trend Tomasco champions: that AI, grounded in solid data, can improve not only efficiency but also product quality and production timelines, positioning companies at the forefront of digital innovation.
Read more about new FDA guidelines here.
Tomasco’s forward-thinking approach extends into the domain of artificial intelligence (AI), where he sees immense potential to revolutionize decision-making processes in biopharma. However, he underscores the need for a robust data foundation to maximize AI’s benefits. “AI is not a magical solution; it’s a powerful tool when paired with robust data,” he explains. Tomasco’s insights align with recent FDA draft guidelines on AI, which aim to clarify the role of AI in drug manufacturing, particularly around quality control, predictive analytics, and real-time decision-making. The FDA emphasizes the importance of data integrity and transparency, reinforcing Tomasco’s advocacy for reliable, quality-focused data practices.
These new FDA guidelines set standards to mitigate risks associated with AI implementation and ensure consistent product quality in biopharma. They support Tomasco’s view on future-proofing by underlining that a solid foundation of data practices must precede AI deployment, enabling companies to enhance production reliability and predictability. These evolving regulatory standards reflect the broader industry trend Tomasco champions: that AI, grounded in solid data, can improve not only efficiency but also product quality and production timelines, positioning companies at the forefront of digital innovation.
Read more about new FDA guidelines here.
Tomasco’s forward-thinking approach extends into the domain of artificial intelligence (AI), where he sees immense potential to revolutionize decision-making processes in biopharma. However, he underscores the need for a robust data foundation to maximize AI’s benefits. “AI is not a magical solution; it’s a powerful tool when paired with robust data,” he explains. Tomasco’s insights align with recent FDA draft guidelines on AI, which aim to clarify the role of AI in drug manufacturing, particularly around quality control, predictive analytics, and real-time decision-making. The FDA emphasizes the importance of data integrity and transparency, reinforcing Tomasco’s advocacy for reliable, quality-focused data practices.
These new FDA guidelines set standards to mitigate risks associated with AI implementation and ensure consistent product quality in biopharma. They support Tomasco’s view on future-proofing by underlining that a solid foundation of data practices must precede AI deployment, enabling companies to enhance production reliability and predictability. These evolving regulatory standards reflect the broader industry trend Tomasco champions: that AI, grounded in solid data, can improve not only efficiency but also product quality and production timelines, positioning companies at the forefront of digital innovation.
Read more about new FDA guidelines here.
Tomasco’s forward-thinking approach extends into the domain of artificial intelligence (AI), where he sees immense potential to revolutionize decision-making processes in biopharma. However, he underscores the need for a robust data foundation to maximize AI’s benefits. “AI is not a magical solution; it’s a powerful tool when paired with robust data,” he explains. Tomasco’s insights align with recent FDA draft guidelines on AI, which aim to clarify the role of AI in drug manufacturing, particularly around quality control, predictive analytics, and real-time decision-making. The FDA emphasizes the importance of data integrity and transparency, reinforcing Tomasco’s advocacy for reliable, quality-focused data practices.
These new FDA guidelines set standards to mitigate risks associated with AI implementation and ensure consistent product quality in biopharma. They support Tomasco’s view on future-proofing by underlining that a solid foundation of data practices must precede AI deployment, enabling companies to enhance production reliability and predictability. These evolving regulatory standards reflect the broader industry trend Tomasco champions: that AI, grounded in solid data, can improve not only efficiency but also product quality and production timelines, positioning companies at the forefront of digital innovation.
Read more about new FDA guidelines here.
A Journey Without an Endpoint
Tomasco’s journey through digital transformation at Pfizer is a testament to the ongoing nature of such initiatives. “It’s a never-ending proposition,” he says, reinforcing that transformation is a process, not a destination. Tomasco’s story serves as a powerful reminder for leaders across industries: the road to transformation requires a commitment to continuous learning, a growth mindset, and a willingness to adapt to evolving challenges. His experiences provide a model for organizations aiming to thrive in a digital-first world, where agility, collaboration, and foresight are indispensable for driving sustainable success.
Tomasco’s journey through digital transformation at Pfizer is a testament to the ongoing nature of such initiatives. “It’s a never-ending proposition,” he says, reinforcing that transformation is a process, not a destination. Tomasco’s story serves as a powerful reminder for leaders across industries: the road to transformation requires a commitment to continuous learning, a growth mindset, and a willingness to adapt to evolving challenges. His experiences provide a model for organizations aiming to thrive in a digital-first world, where agility, collaboration, and foresight are indispensable for driving sustainable success.
Tomasco’s journey through digital transformation at Pfizer is a testament to the ongoing nature of such initiatives. “It’s a never-ending proposition,” he says, reinforcing that transformation is a process, not a destination. Tomasco’s story serves as a powerful reminder for leaders across industries: the road to transformation requires a commitment to continuous learning, a growth mindset, and a willingness to adapt to evolving challenges. His experiences provide a model for organizations aiming to thrive in a digital-first world, where agility, collaboration, and foresight are indispensable for driving sustainable success.
Tomasco’s journey through digital transformation at Pfizer is a testament to the ongoing nature of such initiatives. “It’s a never-ending proposition,” he says, reinforcing that transformation is a process, not a destination. Tomasco’s story serves as a powerful reminder for leaders across industries: the road to transformation requires a commitment to continuous learning, a growth mindset, and a willingness to adapt to evolving challenges. His experiences provide a model for organizations aiming to thrive in a digital-first world, where agility, collaboration, and foresight are indispensable for driving sustainable success.
Mike Tomasco’s digital transformation journey provides a compelling blueprint for how organizations can successfully navigate change in an increasingly complex and data-driven world. His emphasis on adaptability, cross-functional collaboration, and the power of storytelling underscores the leadership qualities needed to foster innovation while maintaining operational stability. Tomasco’s foresight in advocating for user experience and a solid data foundation for AI integration offers invaluable lessons for organizations aiming to harness advanced technologies effectively.
For companies looking to adopt similar AI-driven strategies, KatalyzeAI offers a suite of powerful solutions tailored to streamline decision-making and enhance operational efficiency. With AI tools designed to provide real-time insights and predictive analytics, KatalyzeAI empowers organizations to leverage their data for faster, smarter, and more accurate decision-making.
If you’re aiming to future-proof operations, KatalyzeAI provides the technology and expertise to support your transformation journey.
Mike Tomasco’s digital transformation journey provides a compelling blueprint for how organizations can successfully navigate change in an increasingly complex and data-driven world. His emphasis on adaptability, cross-functional collaboration, and the power of storytelling underscores the leadership qualities needed to foster innovation while maintaining operational stability. Tomasco’s foresight in advocating for user experience and a solid data foundation for AI integration offers invaluable lessons for organizations aiming to harness advanced technologies effectively.
For companies looking to adopt similar AI-driven strategies, KatalyzeAI offers a suite of powerful solutions tailored to streamline decision-making and enhance operational efficiency. With AI tools designed to provide real-time insights and predictive analytics, KatalyzeAI empowers organizations to leverage their data for faster, smarter, and more accurate decision-making.
If you’re aiming to future-proof operations, KatalyzeAI provides the technology and expertise to support your transformation journey.
Mike Tomasco’s digital transformation journey provides a compelling blueprint for how organizations can successfully navigate change in an increasingly complex and data-driven world. His emphasis on adaptability, cross-functional collaboration, and the power of storytelling underscores the leadership qualities needed to foster innovation while maintaining operational stability. Tomasco’s foresight in advocating for user experience and a solid data foundation for AI integration offers invaluable lessons for organizations aiming to harness advanced technologies effectively.
For companies looking to adopt similar AI-driven strategies, KatalyzeAI offers a suite of powerful solutions tailored to streamline decision-making and enhance operational efficiency. With AI tools designed to provide real-time insights and predictive analytics, KatalyzeAI empowers organizations to leverage their data for faster, smarter, and more accurate decision-making.
If you’re aiming to future-proof operations, KatalyzeAI provides the technology and expertise to support your transformation journey.
Mike Tomasco’s digital transformation journey provides a compelling blueprint for how organizations can successfully navigate change in an increasingly complex and data-driven world. His emphasis on adaptability, cross-functional collaboration, and the power of storytelling underscores the leadership qualities needed to foster innovation while maintaining operational stability. Tomasco’s foresight in advocating for user experience and a solid data foundation for AI integration offers invaluable lessons for organizations aiming to harness advanced technologies effectively.
For companies looking to adopt similar AI-driven strategies, KatalyzeAI offers a suite of powerful solutions tailored to streamline decision-making and enhance operational efficiency. With AI tools designed to provide real-time insights and predictive analytics, KatalyzeAI empowers organizations to leverage their data for faster, smarter, and more accurate decision-making.
If you’re aiming to future-proof operations, KatalyzeAI provides the technology and expertise to support your transformation journey.
Mike Tomasco
Mike Tomasco
Mike Tomasco
Mike Tomasco is a Vice President in Pfizer Digital with responsibility for leading Pfizer Global Supply’s (PGS) Digital Transformation. The goal of the program is to transform PGS through a business strategy driven focus on digitization applied end to end across Manufacturing and Supply Operations. Mr. Tomasco has experience across strategy, marketing, finance, manufacturing and information systems for multinational companies and has successfully led several major transformational initiatives.
Mike Tomasco is a Vice President in Pfizer Digital with responsibility for leading Pfizer Global Supply’s (PGS) Digital Transformation. The goal of the program is to transform PGS through a business strategy driven focus on digitization applied end to end across Manufacturing and Supply Operations. Mr. Tomasco has experience across strategy, marketing, finance, manufacturing and information systems for multinational companies and has successfully led several major transformational initiatives.
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
Katalysts Podcast
Subscribe to Gain Insights About AI Solutions
"With Katalyze AI, we can analyze data in real-time and make informed decisions to optimize our processes." Chris Calabretta
More Articles:
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
Harnessing Data and AI in the Manufacturing Sector: Key Insights for Success
Discover how AI and data are transforming manufacturing. Learn from expert Ramila Peiris on overcoming legacy challenges, fostering collaboration, and driving innovation.
Learn more
The Future of AI in Pharmaceutical Manufacturing: Insights from Harini Gopalakrishnan
Explore how AI transforms pharma - from drug discovery to manufacturing - with expert insights from Harini, and learn how Katalyze AI is driving innovation in operational efficiency.
Learn more
Key Learnings from the FDA’s Draft Guidance on AI in Drug Development
Learn more
The AI Revolution in Genetic Medicine: Insights from Lee Bowman
Mediphage's COO, Lee Bowman, discusses AI's impact on genetic medicine, bio-manufacturing efficiency, industry challenges, and the importance of strategic collaboration.
Learn more
